XML 14 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock, Common
Additional Paid-In Capital
Accumulated Other Comprehensive Income / (Loss)
Accumulated Deficit
Beginning Balance at Dec. 31, 2022 $ 489,686 $ 791 $ (47) $ 1,203,074 $ (357) $ (713,775)
Beginning Balance (in shares) at Dec. 31, 2022   79,123,312        
Issuance of common stock pursuant to exercise of stock options 1,114 $ 1   1,113    
Issuance of common stock pursuant to exercise of stock options (in shares)   88,429        
Issuance of common stock pursuant to vesting of restricted stock units   $ 1   (1)    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   126,060        
Issuance of common stock pursuant to exercise of warrants 7 $ 1   6    
Issuance of common stock pursuant to exercise of warrant (in shares)   126,093        
Issuance of common stock pursuant to the at-the-market offering program, net of issuance costs 17,222 $ 10   17,212    
Issuance of common stock pursuant to the at-the-market offering program, net of issuance costs (in shares)   948,300        
Unrealized comprehensive gain (loss) on investments 267       267  
Stock-based compensation 8,915     8,915    
Net loss (58,335)         (58,335)
Ending Balance at Mar. 31, 2023 458,876 $ 804 (47) 1,230,319 (90) (772,110)
Ending Balance (in shares) at Mar. 31, 2023   80,412,194        
Beginning Balance at Dec. 31, 2022 489,686 $ 791 (47) 1,203,074 (357) (713,775)
Beginning Balance (in shares) at Dec. 31, 2022   79,123,312        
Net loss (124,036)          
Ending Balance at Jun. 30, 2023 402,970 $ 805 (47) 1,240,745 (722) (837,811)
Ending Balance (in shares) at Jun. 30, 2023   80,521,415        
Beginning Balance at Mar. 31, 2023 458,876 $ 804 (47) 1,230,319 (90) (772,110)
Beginning Balance (in shares) at Mar. 31, 2023   80,412,194        
Issuance of common stock pursuant to exercise of stock options 182     182    
Issuance of common stock pursuant to exercise of stock options (in shares)   48,088        
Issuance of common stock pursuant to vesting of restricted stock units   $ 1   (1)    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   61,133        
Unrealized comprehensive gain (loss) on investments (632)       (632)  
Stock-based compensation 10,245     10,245    
Net loss (65,701)         (65,701)
Ending Balance at Jun. 30, 2023 402,970 $ 805 $ (47) 1,240,745 (722) (837,811)
Ending Balance (in shares) at Jun. 30, 2023   80,521,415        
Beginning Balance at Dec. 31, 2023 492,574 $ 903   1,450,722 319 (959,370)
Beginning Balance (in shares) at Dec. 31, 2023   90,282,267        
Issuance of common stock pursuant to exercise of stock options 1,184     1,184    
Issuance of common stock pursuant to exercise of stock options (in shares)   73,745        
Issuance of common stock pursuant to vesting of restricted stock units   $ 3   (3)    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   290,578        
Unrealized comprehensive gain (loss) on investments (454)       (454)  
Stock-based compensation 10,252     10,252    
Net loss (62,054)         (62,054)
Ending Balance at Mar. 31, 2024 441,502 $ 906   1,462,155 (135) (1,021,424)
Ending Balance (in shares) at Mar. 31, 2024   90,646,590        
Beginning Balance at Dec. 31, 2023 492,574 $ 903   1,450,722 319 (959,370)
Beginning Balance (in shares) at Dec. 31, 2023   90,282,267        
Net loss (131,700)          
Ending Balance at Jun. 30, 2024 384,635 $ 910   1,475,013 (218) (1,091,070)
Ending Balance (in shares) at Jun. 30, 2024   90,956,613        
Beginning Balance at Mar. 31, 2024 441,502 $ 906   1,462,155 (135) (1,021,424)
Beginning Balance (in shares) at Mar. 31, 2024   90,646,590        
Issuance of common stock pursuant to exercise of stock options 1,530 $ 2   1,528    
Issuance of common stock pursuant to exercise of stock options (in shares)   159,355        
Issuance of common stock pursuant to vesting of restricted stock units   $ 2   (2)    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   150,668        
Unrealized comprehensive gain (loss) on investments (83)       (83)  
Stock-based compensation 11,332     11,332    
Net loss (69,646)         (69,646)
Ending Balance at Jun. 30, 2024 $ 384,635 $ 910   $ 1,475,013 $ (218) $ (1,091,070)
Ending Balance (in shares) at Jun. 30, 2024   90,956,613